omniture
logo
Search
江苏威凯尔医药科技股份有限公司
Media Room

Latest News

rss

PanTRKare™ Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)

NANJING, China, Aug. 12, 2026 /PRNewswire/ -- August 6, the NMPA granted approval to Geneseeq's Pan...

2026-08-12 22:00 3153
PanTRKare™ Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)

Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted

NANJING, China, June 26, 2026 /PRNewswire/ -- Recently, the NDA for Sumecigrel Capsule (formerly kn...

2026-06-26 22:30 4222
Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted

Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval

NANJING, China, June 5, 2026 /PRNewswire/ -- NTRK gene fusions have been identified as oncogenic dr...

2026-06-05 22:00 12121
Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval

Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA

NANJING, China, Jan. 4, 2024 /PRNewswire/ -- On December 28, 2023, Jiangsu Vcare PharmaTech Co., Lt...

2024-01-04 21:05 3154
Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA